CarMax's Upbeat Q2 Spurs Analyst Optimism, But Leverage Keeps DeepValue Caution
Read source articleWhat happened
CarMax reported better-than-expected second-quarter fiscal 2027 results, with revenue and earnings exceeding consensus, prompting several analysts to raise their price targets and earnings estimates. The upbeat results contrasted with the prior quarter's disappointing performance, which had sent shares tumbling over 50% in the preceding twelve months and triggered a CEO change. The DeepValue master report, however, highlighted persistent risks: net debt/EBITDA of 17.9x, interest coverage of just 0.3x, and rising credit losses at CarMax Auto Finance (CAF) tied to 2022-23 vintages. While the recent quarter may signal stabilization in used-vehicle sales and margin improvement, the company's leverage and exposure to funding markets leave little room for execution missteps. Analysts' forecast boosts reflect a more optimistic near-term outlook, but the structural vulnerabilities identified in the master report have not been resolved.
Implication
The post-earnings analyst upgrades may provide short-term momentum, but the stock remains expensive relative to its DCF-based intrinsic value of ~$13.71, implying significant downside risk if the company fails to deleverage. CAF credit losses on 2022-23 loan vintages are still elevated, and a deteriorating macro environment could exacerbate delinquencies, further pressuring earnings. High net debt and weak interest coverage leave CarMax vulnerable to any disruption in asset-backed securities markets, which are crucial for funding its loan portfolio. The abrupt CEO termination in late 2025 adds governance uncertainty, and the interim leadership team must articulate a credible plan to restore profitability and strengthen the balance sheet. Until there is sustained evidence of same-store unit growth, used gross profit improvement, and deleveraging, a cautious stance is warranted; any rally may present an opportunity to reassess exit points.
Thesis delta
The upbeat Q2 results and analyst upgrades do not alter the core bearish thesis; they merely indicate that near-term operating performance may be less bad than feared. However, the fundamental overvaluation and leverage concerns remain unchanged, so the STRONG SELL stance is maintained unless the company demonstrates meaningful balance sheet repair and consistent improvement in credit metrics.
Confidence
moderate